Popular Medication Recalled Over Reduced Efficacy Concerns
A significant recall has been issued for a widely-used medication due to concerns about its efficacy. The Food and Drug Administration (FDA) announced the recall on October 10, affecting 141,984 bottles of generic Atorvastatin Calcium tablets. The recall was prompted by issues related to “failed dissolution specifications,” raising concerns about the medication’s performance.
About Atorvastatin Calcium
Atorvastatin Calcium is one of the most prevalent statins on the market. According to medical expert Dr. Brian Cambi, it is among the two most common, studied, and utilized statins. Statins are designed to help lower cholesterol levels, reducing the risk of fatty deposits in the bloodstream.
Usage Statistics
As of January 2024, a staggering 47 million Americans rely on statins daily for cholesterol management. This highlights the importance of ensuring the effectiveness of medications like Atorvastatin Calcium.
Details of the Recall
- Recall Date: October 10, 2023
- Number of Bottles Recalled: 141,984
- Manufacturer: Alkem Laboratories
- Distributor: Ascend Laboratories
What to Do If Affected
Consumers who suspect that their medication may be part of the recall can check the FDA’s recall page. It is crucial for individuals to verify the pill count, manufacturer, and lot number on their bottle. If the product is included in the recall, patients are advised not to discontinue use abruptly.
Instead, it is essential to consult a healthcare provider for advice on alternative treatments during this period. Careful management of cholesterol levels remains critical for overall health.
